Insider activity at Fennec Pharmaceuticals Inc. has been all selling for a year now: about $11.9 million from eight sellers, and zero buyers in open-market trades.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
7 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters. Big money check: 105 institutions held FENC as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Brughera Marco Maria | Director | Sell | 15,545 | $10.29 | $160K | SEC |
| Sep 1, 2026 | Raykov Rosty | Other | Sell | 10,000 | $12.11 | $121K | SEC |
| Aug 31, 2026 | Sayad Pierre Sargis | Executive Officer | Sell | 12,000 | $12.18 | $146K | SEC |
| Aug 28, 2026 | Andrade Robert | CFO | Sell | 75,000 | $11.78 | $884K | SEC |
| Aug 4, 2026 | Raykov Rosty | Other | Sell | 10,000 | $9.58 | $96K | SEC |
| Jul 2, 2026 | Raykov Rosty | Other | Sell | 9,599 | $10.41 | $100K | SEC |
| Jun 2, 2026 | Raykov Rosty | Director | Sell | 9,747 | $9.62 | $94K | SEC |
| May 12, 2026 | RALLIS CHRIS A | Director | Sell | 8,346 | $7.04 | $59K | SEC |
| May 1, 2026 | Raykov Rosty | Director | Sell | 10,781 | $6.47 | $70K | SEC |
| Apr 2, 2026 | Raykov Rosty | Director | Sell | 10,946 | $6.31 | $69K | SEC |
| Mar 3, 2026 | Raykov Rosty | Director | Sell | 10,079 | $8.36 | $84K | SEC |
| Feb 2, 2026 | Raykov Rosty | Director | Sell | 10,349 | $7.76 | $80K | SEC |
| Jan 5, 2026 | Raykov Rosty | Director | Sell | 10,312 | $7.60 | $78K | SEC |
| Dec 29, 2025 | Southpoint Capital Advisors LP | 10% Owner | Sell | 1,000,000 | $7.50 | $7.5M | SEC |
| Dec 5, 2025 | Raykov Rosty | Director | Sell | 10,000 | $7.54 | $75K | SEC |
In the last 12 months Fennec Pharmaceuticals Inc. insiders made open-market purchases worth about $0 and sales worth about $11.9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in FENC was filed on 2026-09-16.
105 investment managers reported holding FENC in SEC Form 13F filings for Q2 2026.
No congressional trades in FENC were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).